Skip to main content
. 2022 Sep 4;187(6):846–854. doi: 10.1111/bjd.21821

Table 1.

Methods used to report change in pain score in the randomized controlled trials

Reporting of pain outcomes Painful skin conditions (n = 70) Rheumatoid arthritis (n = 245)
Percentage of pain change from baseline 10% (7) 13% (31)
Mean difference (vs. baseline and/or placebo) 76% (53) 75% (184)
Percentage of patients reaching a desirable state 10% (7) 11% (26)
Relative risk reduction 1% (1) 0
Absolute risk reduction 0 0
Number needed to treat 1% (1) 2% (4)
Other 7% (5) 10% (24)